Prostaglandin A1

埃索美拉唑EP杂质E;奥美拉唑N-氧化物;埃索美拉唑镁杂质II(4-甲氧基-2[[(RS)-(5-甲氧基-1H-苯并咪唑-2基) 亚磺酰基]甲基]-3,5-二甲基吡啶 1-氧化物);埃索美拉唑镁杂质 II(4-甲氧基-2[[(RS)-(5-甲氧基-1H-苯并咪唑 -2 基) 亚磺酰基]甲基]-3,5-二甲基吡啶 1-氧化物);埃索美拉唑镁杂质II;埃索美拉唑杂质5;埃索美拉唑杂质E;奥美拉唑-N-氧化物;奥美拉唑相关物质E USP标准品;獐牙菜苦甙;埃索美拉唑镁杂质E(EP);埃索美拉唑杂质B;奥美拉唑氮氧化物;奥美拉唑杂质E;奥美拉唑杂质E(EP) 标准品;埃索美拉唑E;奥美拉唑 E;埃索美拉唑镁杂质;奥美拉唑EP杂质E;埃索美拉唑氮氧化物;埃索美拉唑镁杂质E;奥美拉唑相关物质E;奥美拉唑氮氧化物E

Prostaglandin A1

1H-Benzimidazole,6-methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfinyl]-;Omeprazole N-Oxide;4-methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide;Omeprazole Related Compound E;4-Methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide;6-methoxy-2-[(4-methoxy-3,5-dimethyl-1-oxidopyridin-1-ium-2-yl)methylsulfinyl]-1H-benzimidazole;(R)-4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide;4-METHOXY-2-[[(RS)-5(METHOXY-1H-BENZIMIDAZOL-2-YL) SULFINYL] METHYL]-3,5-DIMETHYLPYRIDINE 1-OXIDE;4-Methoxy-2-{[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl}-3,5-dimethylpyridine 1-oxide;6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;OMEPRAZOL-N-OXIDE;Omeprazole Impurity E;Esomeprazole impurity E;Omeprazole EP Impurity E;Esomeprazole EP Impurity B;Esomeprazole EP Impurity E;Esomeprazole Magnesium Impurity;EsoMeprazole related substance E

14152-28-4

C₁₇H₁₉N₃O₄S

361.42

Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Cancer||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway